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Radiofrequency ablation of small liver
malignancies under magnetic resonance
guidance: progress in targeting and preliminary
observations with temperature monitoring
Abstract Objectives: To evaluate
the feasibility and effectiveness of
magnetic resonance (MR)-guided
radiofrequency (RF) ablation for
small liver tumours with poor con-
spicuity on both contrast-enhanced
ultrasonography (US) and computed
tomography (CT), using fast naviga-
tion and temperature monitoring.
Methods: Sixteen malignant liver
nodules (long-axis diameter, 0.6–
2.4 cm) were treated with multipolar
RF ablation on a 1.5-T wide-bore MR
system in ten patients. Targeting was
performed interactively, using a fast
steady-state free precession sequence.
Real-time MR-based temperature
mapping was performed, using gra-
dient echo–echo planar imaging
(GRE-EPI) and hardware filtering.
MR-specific treatment data were re-
corded. The mean follow-up time was
19±7 months. Results: Correct
placement of RF electrodes was
obtained in all procedures (image
update, <500 ms; mean targeting
time, 21±11 min). MR thermometry
was available for 14 of 16 nodules
(88%) with an accuracy of 1.6°C in a
non-heated region. No correlation was
found between the size of the lethal
thermal dose and the ablation zone at
follow-up imaging. The primary and
secondary effectiveness rates were
100% and 91%, respectively.
Conclusions: RF ablation of small
liver tumours can be planned, tar-
geted, monitored and controlled with
MR imaging within acceptable pro-
cedure times. Temperature mapping is
technically feasible, but the clinical
benefit remains to be proven.
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Introduction
Image-guided radiofrequency (RF) ablation is gaining
increasing acceptance as a local treatment of malignant
hepatic lesions in well-defined clinical settings [1–4].
Ultrasonography (US) and computed tomography (CT) are
currently the preferred imaging methods for guidance of RF
ablation, as they are readily available, quick, precise and
accessible at acceptable cost. However, magnetic resonance
(MR) imagingwith specific contrastmaterials is currently the
most sensitive method for detecting liver tumours [5–7] and
some small neoplastic nodules are only visible with this
imagingmodality. Therefore, it is desirable in some instances
to be able to perform RF ablation under MR guidance. In
addition,MR imaging at high field (1 Tand above) is also the
only technique that offers the potential to map temperature
and energy deposition of tissue during the ablation proce-
dure, thus enabling the operator to monitor the progress and
define the endpoint of energy deposition [8–10].
Although RF ablation is the preferred technique for local
treatment of liver tumours of limited size, the number of
clinical reports in the literature on MR-guided RF ablation is
still limited. Some preliminary studies have demonstrated
that MR-based targeting is lengthy, requiring dedicated
hardware and software and long periods of protected time in
the MR suite [11–14]. Nonetheless, these studies have
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demonstrated the feasibility of targeting either with low-field
open or closed-bore MR systems. Most interventionists
currently rely on empirical parameters for energy deposition,
rather than direct monitoring of tissue changes induced by
RF energy. The clinical experience of real-time monitoring
by MR thermometry is now very limited, due to technical
difficulties, such as RF generator interference with MR
image acquisition [15].
Image-guided tumour ablation has been defined in distinct
steps, namely planning, targeting, monitoring, controlling
and follow-up [16]. The purpose of this studywas to evaluate
whether all these steps, including RF electrode targeting
under high temporal resolution navigation and monitoring of
temperature and energy deposition during RF application,
can be performed effectively in small liver tumours that are
detectable only with MR imaging.
Materials and methods
Patients and lesions
From November 2006 to October 2008, a total of 98
malignant hepatic tumours in 61 patients not suitable for
surgical resection were treated with image-guided RF
ablation in our institution. Following multidisciplinary
discussion and informed consent, 53 treatment sessions
(66%) were performed under US guidance, 15 sessions
(19%) under CT guidance, and 12 sessions (15%) under MR
guidance. The MR-guided procedures form the basis of this
prospective study, which was approved by the institutional
ethics review board.
Sixteen malignant hepatic nodules in 10 patients (six
men, four women; age, 63±7 years; range, 54–79) were
readily visible on T1- or T2-weighted MR images, but
either invisible or not sufficiently conspicuous with
contrast-enhanced US and CT (Table 1). Three patients
had hepatocellular carcinoma (HCC) in cirrhosis, diag-
nosed according to international guidelines with imaging
(n=2) or MR-guided biopsy (n=1) [17]. Six patients with
known colorectal cancer had liver metastases, diagnosed
with imaging (n=5) or MR-guided biopsy (n=1). One
patient had local progressive disease in the periphery of a
single liver metastasis from squamous cell carcinoma of the
right upper pulmonary lobe. The mean long-axis diameter
of the nodules was 1.5±0.5 cm (0.6–2.4). Seven nodules
were located within 5 mm from vessels larger than 3 mm,
whereas three nodules were located within 5 mm from the
liver capsule.
MR-compatible RF ablation system
RF ablation was performed with a 470-kHz multipolar RF
generator (Celon AG, Teltow, Germany) coupled with one
or two internally cooled MR-compatible electrodes (active
tip length, 3 cm; shaft length, 15 cm) [18, 19]. The
algorithm of energy deposition was based on the
manufacturer’s guidelines for power settings and included
the resistance-controlled automatic power (RCAP) mode.
External hardware filtering of the transmission line was
implemented between the RF generator and the electrodes, in
order to reduce interference between generator harmonics
and MR image acquisition frequency (Fig. 1). Stop-band
RLC filters, tuned to 63.5 MHz and associated with ferrite
cores, were placed inside the Faraday cage. The manufac-
turer approved these modifications and preliminary testing
on gel phantoms and in vivo in pigs enabled us to perform
simultaneous RF application and MR imaging safely and
with acceptable image quality.
Radiofrequency ablation procedures
A radiologist experienced in hepatobiliary interventions and
RF ablation for 8 years performed the twelve RF treatment
sessions under general anaesthesia with an MR-compatible
anaesthesia machine and monitoring devices. A prophylactic
dose of 2 g of ceftriaxonewas intravenously administered 1 h
before the procedure and was repeated twice over 48 h.
Diagnostic imaging and RF ablation procedures were
performed on a 1.5-T interventional MR system (Espree;
Siemens, Erlangen, Germany) with a closed bore (inner
diameter, 70 cm; length, 120 cm) [12]. Patients were placed
feet first on the MR table in either supine or left lateral
decubitus position. The MR signal was received by six
elements of a spine matrix coil and a 19-cm-diameter loop
surface coil. A breathing sensor was placed around the chest
wall for respiratory gating.
Planning
The RF electrode trajectory was planned from the entry point
to the target tumour, avoiding critical structures, by using
multiplanar reconstructions (MPR) of the 3D acquisition.
Two orthogonal and oblique planes including the trajectory
line were selected and transferred to the graphical slice-
positioning (GSP) software of an in-room user interface
(Interactive Frontend; Siemens, Erlangen, Germany). The
entry point was determined by moving the little finger at the
skin surface.
The pre-procedural imaging protocol included a T2-
weighted half-Fourier acquisition single-shot turbo spin-
echo (HASTE) sequence (repetition time (TR), 1,000 ms;
echo time (TE), 83 ms; slice thickness, 4 mm) and a T2-
weighted segmented turbo spin-echo (TSE) sequence with
fat saturation (TR, 6,000 ms; TE, 104 ms; slice thickness,
6 mm), obtained in the transverse plane with navigator
triggering. A high-resolution isotropic T1-weighted volume-
interpolated breath-hold examination (VIBE) sequence with
fat saturation (TR, 5.6ms; TE, 2.7 ms; slice thickness, 2 mm)
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was acquired in the transverse orientation. If the lesion was
not sufficiently visible on the T1-weightedVIBE sequence, it
was repeated 20 min after a slow infusion of 0.5 μmol/kg of
body weight of mangafodipir (Teslascan; GE Healthcare,
Oslo, Norway).
Targeting
The patient was draped in a sterile fashion including the
surface coil. The interventional radiologist incised the skin
at the entry point, moved the RF electrode forward and
followed its progression in almost real time on the MR-
compatible monitor of the user interface placed next to the
magnet bore. “Fluoroscopic”MR images were obtained on
both axial and sagittal oblique perpendicular planes, which
were interactively readjusted to the actual location of the
RF electrode by a physicist inside the MR-suite controlling
the GSP software with an MR-compatible mouse.
The interventional sequence was a dedicated, balanced
steady-state free precession (bSSFP) interleaved radial
sequence that was specially designed for the purpose of
MR-guided interventions (IRTTT; Siemens, Erlangen,
Germany) and consisted of the following image parameters:
radial views, 64; sliding window width, 5; TR, 4.3 ms; TE,
2.2 ms; flip angle (FA), 70°; bandwidth (BW) 558 Hz/pixel;
matrix, 128×128; voxel size, 3×3×5 mm3; update rate,
275 ms. The bSSFP contrast produced predominantly T2-
weighted images, but when necessary, a 90° saturation RF
pulse was applied to obtain a predominant T1-weighting,
which decreased the update rate to 475 ms.
A total of 20 RF electrodes were placed under MR
fluoroscopy (Table 2). For 12 lesions, a single bipolar
electrode was positioned at the centre of the tumour. Two
electrodes were placed at the periphery of the target tumour
when its long-axis diameter exceeded 2 cm (n=2) or when
lying in contact with a large hepatic vessel (n=2) [19]. The
final position of the RF electrodes with regard to the index
tumour was verified on the 3D T1-weighted VIBE
sequence. The distance between the target position and
the centre of the active tip of the RF electrode was
calculated according to their xyz coordinates with an open-
source DICOM viewer (The OsiriX Foundation, Geneva,
Switzerland) [20]. The duration of targeting was defined
from the initial insertion of each electrode and confirmation
of an acceptable position within the tumour.
RF ablation with temperature monitoring
RF energy application was done with settings as indicated
by the manufacturer and in the same way as we usually
Table 1 Characteristics of the patients and their malignant hepatic nodules
Patient Prior treatment Lesion number Tumour histology Long-axis diameter (cm) Short-axis diameter (cm) Vessel vicinity
A TACE 1 HCC 2.4 2.0 PV
B Resection 2 CRM 2.1 1.5 –
3 CRM 1.6 1.1 HV
4 CRM 1.8 1.2 –
C Resection 5 CRM 1.8 1.0 HV
6a CRM 1.4 0.9 HV
D Resection 7 CRM 1.3 1.2 IVC
8 CRM 1.3 0.7 –
E Resection 9 CRM 1.8 1.1 –
F RFA 10 LUM 1.8 1.3 –
11 LUM 1.7 1.2 HV
G – 12b CRM 0.8 0.6 –
H TACE 13 HCC 1.4 1.0 PV
I – 14 HCC 1.6 1.3 –
J – 15c CRM 0.9 0.7 –
16c CRM 0.6 0.5 –
The diameter of the nodules was 1.5±0.5 cm (0.6–2.4 cm) in the long-axis and 1.1±0.4 cm (0.5–2.0 cm) in the short-axis, with
corresponding volumes of 1.2±1.2 cm3 (0.1–5.0 cm3)
RFA radiofrequency ablation (under US guidance), TACE transarterial chemoembolisation, CRM metastasis from colorectal carcinoma, HCC
hepatocellular carcinoma, LUM metastasis from squamous cell carcinoma of the lung, HV hepatic vein, IVC inferior vena cava, PV portal
vein
aRetreatment of the local tumour progression of lesion 5
bMetachronous metastasis in the left lobe prior to extended right hepatectomy
cMetachronous metastases in the right lobe prior to extended left hepatectomy
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perform RF ablation under US or CT guidance. The
physical parameters for each lesion were monitored on the
first screen of an external PC (Table 2). At the end of RF
application, electrode track coagulation was systematically
performed.
MR thermometry was performed simultaneously during
RF ablation, using the proton resonance frequency shift
(PRFS) method and a lipid-suppressed segmented gradient
echo–echo planar imaging (GRE-EPI) hybrid sequence, as
already described and validated [21]. Three parallel slices
were acquired in a single plane during the expiratory phase
by means of pressure-sensor triggering, with the central
slice positioned along the RF electrodes. Image parameters
included: echo train length (ETL), 13; TR, 50 ms; TE,
20 ms; FA, 25°; BW, 1,000 Hz/pixel; matrix, 128×128;
voxel size, 2.3×2.3×6.0 mm3; slice gap, 1.2 mm. The
acquisition time was 0.6 s per slice and the sampling rate
was equal to the respiratory frequency.
The magnitude and phase images were transferred on-
line to the external PC for post-processing. The relative
temperature measurements were derived from the time
series of phase images and continuously processed with
dedicated C++ software (Image Guided Therapy, Pessac,
France). A nasopharyngeal transducer monitored body
temperature. The lethal thermal dose was calculated
according to the empirical model of Sapareto [8, 22].
During RF application, the absolute isotherms and lethal
thermal dose were displayed in real time on the second
screen of the external PC (Table 3).
The SNR of the magnitude images and the temperature
standard deviation (SD) in a non-heated region of interest
(ROI) were calculated for each image in the dynamic series
to characterize the efficiency of the RF device filtering and
the temperature accuracy, respectively. Two radiologists
qualitatively assessed the image quality of the isotherms
and thermal dose maps.
Fig. 1 Schematic of MR-compatible RF ablation setup. A
commercial RF generator is placed outside the Faraday cage (FC).
Coaxial cables connect the RF generator inside the FC with BNC
(Bayonet Neill Concelman) connectors placed on a dedicated panel
outside the FC. Inside the FC, the AC signal is filtered using, for
each of the two lines, six stop-band passive parallel filter cells
composed of resistors (R), inductors (L) and variable capacitors (C).
The shield of the coaxial cables and the filter is connected to the
same potential as the FC. The cable between the filter box and the
RF electrode is further filtered using three ferrite cores. The plastic
tubes of the water circuit for internal cooling of the electrode go in
and out through two waveguides of the FC. The generator was
connected to the RF electrode after final positioning of the RF
electrode. RF power is then applied simultaneously with the MR
thermometry imaging
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Controlling
At the end of RF application, electrode track coagulation was
systematically performed. Post-ablation imaging protocol
included the same T2-weighted HASTE and TSE sequences
as used for the initial planning. Complete ablation was
assumed when high T2 signal intensity was replaced by low
signal intensity surrounded by a rim of high signal,
encompassing the index tumour with an intended ablative
margin of 5 mm. If remaining high signal intensity indicated
residual tumour tissue, additional RF application was
performed after repositioning of the electrodes.
The overall duration of the interventions from the
admission to the exit of the patient from the MR suite was
recorded according to the anaesthesia protocol.
Follow-up and clinical outcome
All patients stayed in the hospital overnight for medical
observation and laboratory follow-up and were discharged
after recovery. Twenty-four hours after RF procedure, a
quadriphasic CT examination (section thickness, 2.0 mm;
reconstruction interval, 1.0 mm) with intravenous contrast
injection (Accupaque 350; GE Healthcare, Oslo, Norway;
2 mL/kg; rate, 3–5 mL/s) was performed for early
complications.
Description of the results of RF ablation was based
on international recommendations according to standard
criteria [16, 23]. Follow-up consisted in MR imaging
with hepato-specific contrast and monitoring of tumour
markers at 1 week, 1 month and every 3 months. The
primary technique effectiveness was assessed 1 month
after a single RF session. Any hyperintensity on T2-
weighted images or non-enhancing area on contrast-
enhanced MR images at the boundaries of the treated
area was considered as incomplete ablation. Local
tumour progression was determined on subsequent
follow-up imaging and the secondary technique effec-
tiveness was evaluated in patients with 1-year or more
follow-up.
Statistical analysis
Descriptive statistical values were presented as means, SD
and ranges. Contrast-to-noise ratio (CNR) was calculated
between liver and tumour, RF electrode or hepatic vessels:
CNR ¼ SI1  SI2ð Þ=SDnoisej j , where SI1 is the signal inten-
sity of the liver parenchyma, SI2 is the signal intensity of the
tumour, the RF electrodes or the hepatic vessels, and SDnoise
is the SD of the background noise. Statistical analysis was
performed with a commercially software (Prism version 5.0
for MacOsX; GraphPad Software, La Jolla, USA). Compar-
Table 2 Physical parameters during RF ablation
Patient Session
number
Lesion
number
Number of RF
electrodes
Output power
(W)
Effective power
(W)
Total duration
(min)
Total energy
(kJ)
A I 1 2a 60/40 22.5 32.8 30.8
B II 2 2 60 35.9 23.2 50.1
III 3 2 60 40.9 15.0 36.1
4 1 30 17.3 18.6 15.0
C IV 5 2a 60/20 32.5 46.4 75.9
V 6 1a 30/25 20.2 18.4 20.2
D VI 7 1 50 36.8 18.1 40.0
8 1b 30 19.5 14.2 19.8
E VII 9 1 30 17.7 15.8 16.7
F VIII 10 1 30 13.3 33.2 26.5
11 1 30 16.9 19.3 19.5
G IX 12 1a 30/20 19.9 36.7 36.2
H X 13 1 30 19.1 22.0 25.3
I XI 14 1 30 18.5 19.5 22.1
J XII 15c 1 30 19.7 18.0 24.3
16c 1 30 17.4 16.2 19.3
Effective power is the mean power during the whole procedure. A mean output power of 36.6±11.7 W (20.0–60.0 W), with a corresponding
mean effective power of 23.0±8.4 W (13.3–40.9 W), was applied during 22.9±9.3 min (14.2–46.4 min) for a total energy deposition of
29.9±15.6 kJ (15.0–75.9 kJ)
aRF electrode repositioning
bRF electrode retraction
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isons of the CNR measurements were performed with
Mann–Withney U test. The duration of targeting on
consecutive RF ablations was assessed with non-linear
regression analysis. Spearman correlation coefficient was
calculated to compare the size of lethal thermal dose with the
ablation zone on imaging follow-up in the same imaging
plane.
Results
Radiofrequency ablation procedures
The 12 RF sessions were completed under MR guidance in
all cases. The overall duration of the interventions was
194±33 min (141–256). At the end of each intervention,
Table 3 Qualitative and quantitative parameters of temperature monitoring during RF ablation
Lethal thermal dose during RF ablation Ablation zone at 1-week MRI
Lesion
number
Imaging
plane
SNR T° SD
(°C)
Image
qualitya
Long-axis diameter
(cm)
Short-axis diameter
(cm)
Long-axis diameter
(cm)
Short-axis diameter
(cm)
1 Oblique
coronal
16 N/A Insufficient – – 4.2 2.3
2 Oblique
sagittal
23 1.7 Insufficient – – 3.8 2.5
3 Oblique
sagittal
34 0.8 Acceptable 3.9 2.6 4.4 2.4
4 Oblique
axial
32 1.0 Acceptable 2.7 1.5 2.8 2.3
5 Oblique
axial
26 1.4 Acceptable 5.9 4.5 3.3 3.1
6 Oblique
sagittal
22 3.0 Acceptable 1.9 1.3 4.3 3.4
7 Oblique
axial
26 0.7 Adequate 3.2 2.4 3.3 2.4
8 Oblique
axial
37 2.0 Adequate 2.4 1.8 3.3 2.3
9 Oblique
axial
11 3.5 Acceptable 3.1 2.1 4.2 2.2
10 Oblique
sagittal
34 2.0 Acceptable 2.8 1.6 2.7 1.9
11 Oblique
axial
40 1.7 Adequate 3.2 1.9 3.8 1.7
12 Oblique
sagittal
22 1.6 Insufficient – – 3.7 2.6
13 Oblique
axial
38 1.2 Adequate 2.7 1.7 3.2 2.2
14 Oblique
axial
31 1.4 Acceptable 2.4 1.5 2.9 1.9
15 Oblique
axial
26 0.8 Adequate 3.5 2.2 3.9 2.0
16 Oblique
sagittal
16 N/A Insufficient – – 3.6 1.9
The mean SNR was 27.1±8.5 (11.0–40.0) and the temperature accuracy was 1.6±0.8°C (0.7–3.5). The final thermal dose maps on the
central slice were compared with the ablation zone on the MR imaging at 1 week, but Spearman analysis did not reveal any correlation
between the long-axis diameters (r=0.301; P=0.342) and the short-axis diameters (r=0.219; P=0.494), respectively
SNR signal-to-noise ratio of the magnitude images, calculated as the mean of signal in a non-heated region of interest (ROI) more than 5 cm
away from the RF electrode, divided by the standard deviation (SD) of pixels in a background noise ROI of 100 pixels, for each image in
the dynamic series; T° SD mean standard deviation of temperature in the same non-heated ROI; N/A not available
aCriteria for image quality: adequate, no significant noise and lethal thermal dose is quantifiable; acceptable, significant noise, but lethal
thermal dose is still visible; insufficient, significant noise that degrades the image to a great extent and the thermal maps are barely visible
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complete tumour coverage by the ablation zone was
obtained for the 16 malignant nodules, as assessed on T2-
weighted images, for a technical success rate of 100%.
Planning
The conspicuity of seven lesions, which were not
sufficiently visible on the unenhanced T1-weighted VIBE
sequence CNR ¼ 14 9ð Þ , was improved by the infusion
of mangafodipir CNR ¼ 33 20ð Þ . The T2-weighted
HASTE CNR ¼ 22 14ð Þ and TSE with fat saturation
CNR ¼ 38 17ð Þ sequences were useful to distinguish
local tumour progression from a previous ablation zone
(n=2) or changes at the site of resection (n=3).
The RF electrode trajectory was easily planned with
MPR techniques on the 3D T1-weighted VIBE acquisition
and measured 10.9±3.5 cm (6.0–15.5).
Targeting
The MR-compatible components of the in-room user
interface did not interfere with sterility requirements,
anaesthesia monitoring or placement of the RF electrode.
The only drawback was that the operator’s position needed
Fig. 2 Targeting under MR imaging of a recurrent nodule (lesion 4)
in a 54-year-old woman (patient B) after right hepatectomy with
four wedge resections for synchronous liver metastases of colorectal
origin. a 3D T1-weighted VIBE images (TR, 5.6 ms; TE, 2.7 ms;
FA, 10°; matrix, 320×256; section thickness, 2 mm) reconstructed
in the axial oblique plane (top) and sagittal oblique plane (bottom)
are used for planning. A 1.8-cm large, irregular and hypointense
nodule (black arrows) at the posterior and inferior aspect of segment
4 and in contact with the site of a previous metastasectomy. b
“Fluoroscopic” bSSFP sequence (TR, 4.3 ms; TE, 2.2 ms; FA, 70°;
matrix, 128×128; section thickness 5 mm) shows the RF electrode
9 min and 14 s after its insertion at the entry site. The predominantly
T1-weighted image (update rate, 475 ms) in the axial oblique plane
(top) shows the proximity of the electrode tip with regard to the
metastatic nodule (white arrow), whereas the predominantly T2-
weighted image (update rate, 275 ms) in the sagittal oblique plane
(bottom) demonstrates its relation with the left branch of the portal
vein (white arrowheads). c At the end of the targeting procedure, a
new 3D T1-weighted VIBE acquisition shows the final position of
the active tip of the RF electrode within the tumour nodule in both
orthogonal oblique planes
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to be adapted to the magnet’s bore during the initial
targeting procedure.
Both T1- and T2-weighted variants of the bSSFP
imaging sequence were useful in the targeting procedure
(Fig. 2). The CNR measurements showed better tumour
conspicuity on the T1-weighted images, whereas the
vascular structures were better visualized on the T2-
weighted images (Fig. 3). The width of the susceptibility
artefact of the RF electrode was 0.6±0.2 cm and 0.8±
0.3 cm on the T1- and T2-weighted images, respectively,
without statistically significant difference between the
oblique axial and sagittal planes.
During the 20 electrode placements, correct targeting
was achieved with a precision of 0.4±0.2 cm (0.1–0.8) and
the duration of targeting was 21±11 min (8–48). A typical
learning curve was observed, which showed an initial
reduction of targeting time to reach a plateau on subsequent
procedures (Fig. 4). Conversely, no correlation was
observed between the distance of the tumour from the
skin surface and the duration of targeting.
RF ablation with temperature monitoring
Hardware filtering provided a mean attenuation of −95±
5 dB at 63.5 MHz. The same SNR in magnitude images
was obtained with the generator in standby mode or
power application mode, regardless of the actual power
level and duration for a specific procedure (P=0.768).
MR thermometry was achievable during RF ablation in
14 of the 16 treated nodules (88%) with a mean SD of
1.6°C in a non-heated ROI (Fig. 5). The final lethal
thermal dose was assessable in 12 of the 16 RF
applications (75%).
The width of the susceptibility artefact of the RF
electrode was 1.2±0.3 cm, without statistically significant
difference over the series of treatments regardless of the
imaging plane. Image quality for the GRE-EPI sequence
was better when acquisition was performed in the oblique
axial than in the oblique sagittal or coronal plane. The
cause of insufficient image quality was mainly related to
problems of respiratory triggering, when general anaesthe-
sia was suboptimal and the patient presented involuntary
diaphragm contraction.
No statistically significant correlation was found
between the size of the lethal thermal dose and the
ablation zone at 24-h CT, 1-week, 1-month or 3-month
MR imaging. In four nodules close to a large hepatic
vessel, the thermal dose maps revealed local asymmetry
with a thinning or a notch at the side of the vessel
(Fig. 6).
Controlling
At the end of RF application, four ablation zones showed
residual hyperintensity on T2-weighted images at their
boundaries that were interpreted as incomplete ablation.
After repositioning of the electrode, a second ablation was
performed in order to obtain complete tumour coverage.
The second procedure resulted in signal loss in all
instances.
Fig. 3 Graph shows the CNR of T1-weighted bSSFP images (T1-w
IRTTT in grey) and T2-weighted bSSFP images (T2-w IRTTT in
white) in three situations: CNR of the tumour target, the hepatic
vessels or the RF electrode with regard to liver parenchyma. Boxes
represent the interquartile range, which contains 50% of values.
Lines across the boxes indicate the median, whereas error bars
indicate maximum and minimum values. Asterisks specify a
statistically significant difference between two unpaired groups for
tumour (P=0.0001) and vessels (P=0.0003), but not for the RF
electrode (P=0.871)
Fig. 4 The targeting learning curve. The duration of targeting was
28±11 min for the initial procedures (black circles; n=10) and 13±
4 min for the following ones (white circles; n=10) with a
statistically significant difference (P=0.0008) between these two
groups. The values are correctly fitted by (R2=0.869) one-phase
decay exponential regression (solid curve) within a 95% confidence
interval (dashed curves)
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Follow-up and clinical outcome
The mean duration of hospitalisation was 2.3±0.7 days
(1.1–3.7). There were no major complications related to the
ablation procedure. One minor complication (8.3%)
occurred among the 12 RF sessions and consisted in a
first-degree skin burn at the puncture site. This was related
to track ablation and resolved completely after topical
application of diclofenac cream and oral intake of ibupro-
fen. Post-ablation syndrome occurred after two RF sessions
(17%), but was self-limited and did not significantly
lengthen the hospital stay.
Fig. 5 RF ablation with real-time monitoring of the same nodule
shown in Fig. 2. a The successive isotherms (top) and thermal dose
(bottom) images on the central slice of GRE-EPI sequence (ETL, 13;
TR, 50 ms; TE, 20 ms; FA, 25°; matrix, 128×128; section thickness,
6 mm; plane, axial) show the time evolution (left to right: t=5.5 s;
t=132 s; t=330 s; t=1,175 s) of isotherms and thermal dose maps,
respectively. Colour range is set from 42 to 65°C (top) and regions
above one lethal threshold of cumulative thermal dose (bottom),
corresponding to 240 equivalent minutes at 43°C, are shown in red.
The width of susceptibility artefact of the RF electrode is 1.8 cm. b
Temperature evolution during the RF ablation on the same
timescale. A non-heated ROI was selected (blue ROI in Fig. 5a)
to monitor the standard deviation of temperature (SD=1.0°C) (solid
black line). One pixel was selected on the thermal maps (green cross
in Fig. 5a) to illustrate the temperature time evolution (red crosses).
Three phases are observed: the baseline, the rapid increase and the
stabilization of temperature. The uncertainty of temperature in the
heated region is higher than in the non-heated region
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The mean follow-up period was 19±7 months (3–26). At
1-month MR imaging, complete tumour destruction was
achieved after one RF session in all 16 malignancies, for a
primary effectiveness rate of 100%. On subsequent follow-
up, local tumour progression was observed in two patients
at 3 and 10 months. In patient C, the local tumour
progression was successfully re-treated under MR guid-
ance. Secondary technique effectiveness was observed in
10 of the 11 tumours (91%) with 1-year or more follow-up.
New hepatic and extra-hepatic tumours appeared in two
patients with metastases from colorectal cancer and in the
patient with metastases from lung carcinoma. No tumour
seeding was observed during follow-up. One patient with
colorectal cancer died from disseminated disease 17months
after RF ablation.
Discussion
The present study shows that RF ablation of small liver
tumours can be done entirely and effectively with MR
guidance. It is well known that some small liver neoplasms
cannot be well visualised with contrast-enhanced US or
CT. Such nodules may still be amenable to image-guided
treatment by combining different techniques, such as CT–
US fusion imaging-guided RF ablation, intraoperative RF
ablation or combined TACE and RF ablation for HCC.
However, none of our ten patients could have been treated
with RF ablation alone without using our technique. From
a practical point of view, MR-guided electrode placement
has generally been a lengthy procedure, thus occupying
precious machine time that is usually for diagnostic
imaging and hampering the development of MR imaging
for interventional purposes in many institutions. The
dedicated interventional MR system used in this study
enabled us to overcome this drawback by significantly
reducing the time for targeting.
The hardware components adapted to the MR environ-
ment proved suitable for the interventional procedure. The
70-cm-diameter bore of the magnet, as well as the flexible
coil, provided adequate space and distances for interven-
tion under antiseptic conditions. The “interventional”
bSSFP sequence provided sufficient CNR for the targeting
of most lesions, and when adding the T1-weighted images
Fig. 6 Monitoring and control-
ling of RF ablation in a 57-year-
old man (patient D) with a
metastatic nodule from colorec-
tal cancer (lesion 7) in segment
1, which was already treated by
RF ablation under US guidance.
a Axial HASTE T2-weighted
image (TR, 1,000 ms; TE,
83 ms; FA, 150°; matrix size,
256×224; section thickness,
4 mm) shows a 1.3-cm large
nodule (white arrow) with hy-
perintense signal, corresponding
to local tumour progression
within the ablation zone in close
contact with the inferior vena
cava (IVC). b,c Temperature (b)
and thermal dose (c) maps on
the central slice of GRE-EPI
sequence (ETL, 13; TR, 50 ms;
TE, 20 ms; FA, 25°; matrix,
128×128; section thickness,
6 mm; plane, axial) at the end of
RF ablation (1,094.5 s or 199
dynamics) show frank asymme-
try in shape, because the RF
electrode is placed between the
tumour nodule and the IVC,
which results in an important
heat sink effect. d Axial HASTE
T2-weighted image at immedi-
ate control after RF ablation
shows the typical signal drop
within the ablation zone (white
arrowheads). At 15-month fol-
low-up, no local tumour pro-
gression was detected by MR
imaging (not shown) and the
IVC was still patent
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with hepato-specific contrast materials, all lesions could be
targeted adequately. Furthermore, the high temporal reso-
lution of the bSSFP sequence with the multiplanar
capabilities of the GSP software rendered the MR-guided
procedure faster than with previously reported MR-based
techniques [11–13]. In a recent study, the authors reported
similar findings for MR-guided RF ablation of renal cell
carcinoma in two patients [14]. With increasing practical
experience, it should be possible to further reduce the
procedure duration.
The concept of thermal dose mapping is currently the
only semi-quantitative criteria used to predict heat-induced
tissue damage [22]. So far, few papers have reported
studies of in vivo MR thermometry under RF heating. Two
animal studies compared thermal dose and the final
ablation zone, but showed controversial results [24, 25];
and one case report described the use temperature
monitoring during RF ablation in a cirrhotic patient [15].
Ideally, it is desirable to define a patient-specific endpoint
for RF energy deposition based on real-time MR ther-
mometry data. By using the current filtering technique,
temperature and thermal dose maps can be obtained
simultaneously during RF application in most cases. This
is in contrast with the previously reported technique of
switching between power application and imaging, which
significantly lengthens the procedure [26]. Nonetheless,
the clinical usefulness of thermal dose mapping remains
questionable and the T2-based signal changes after
application of an empirically determined dose of energy
appears to be a more reliable indicator for the endpoint of
RF ablation [27, 28].
The PRFS-based MR-thermometry should be more
systematically accurate to assess for the validity of
empirical thermal dose model, whereas correlation studies
with a larger number of patients are needed in the future.
Further technical refinements should focus on the RF
electrode’s alloy formulation in order to minimise the
susceptibility artefact on MR images, which may cancel the
temperature signal exactly where it should have been
measured. Another issue to be addressed is the robustness
of the GRE-EPI temperature images toward liver respira-
tory motion, since trough-plane motion may affect the
accuracy of thermometry. More sophisticated techniques,
such as multi-reference or reference-less methods, may
lead to improvements in the future [29, 30]. Even though
the actual software acquires only three parallel slices in a
single plane, it seems that image quality is also dependent
on the imaging plane orientation. Further development
should include MR monitoring of temperature variations in
three orthogonal slices, a first step toward 3D thermometry.
In conclusion, our preliminary clinical experience
suggests that all steps of RF ablation, namely planning,
targeting, monitoring and controlling, are technically
feasible with MR imaging. The interactive targeting
mode enables effective and sufficiently rapid electrode
placement in clinical practice. Additional clinical experi-
ence is needed to determine if thermal dose mapping can be
used to determine the endpoint of RF ablation. Such future
improvements could help to render RF ablation of liver
tumours more precise and reproducible, especially when
the nodule is close to a large vessel and the perfusion-
mediated tissue cooling affects the evolution of the ablation
zone.
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